
### [NCIT:C39854](http://purl.obolibrary.org/obo/NCIT_C39854)
**Label:** Non-Invasive Urothelial Neoplasm

**Subclasses:** [NCIT:C3842](http://purl.obolibrary.org/obo/NCIT_C3842) (Urothelial Papilloma), [NCIT:C4597](http://purl.obolibrary.org/obo/NCIT_C4597) (Stage 0is Renal Pelvis Urothelial Carcinoma), [NCIT:C3644](http://purl.obolibrary.org/obo/NCIT_C3644) (Stage 0is Bladder Urothelial Carcinoma), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C9267](http://purl.obolibrary.org/obo/NCIT_C9267) (Stage 0a Bladder Urothelial Carcinoma), [NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade), [NCIT:C39850](http://purl.obolibrary.org/obo/NCIT_C39850) (Stage 0 Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C39831](http://purl.obolibrary.org/obo/NCIT_C39831) (Non-Invasive Bladder Papillary Urothelial Neoplasm), [NCIT:C6160](http://purl.obolibrary.org/obo/NCIT_C6160) (Ureter Urothelial Papilloma), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C39858](http://purl.obolibrary.org/obo/NCIT_C39858) (Bladder Urothelial Papilloma), [NCIT:C7517](http://purl.obolibrary.org/obo/NCIT_C7517) (Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C27882](http://purl.obolibrary.org/obo/NCIT_C27882) (Bladder Low Grade Intraurothelial Neoplasia), [NCIT:C7518](http://purl.obolibrary.org/obo/NCIT_C7518) (Stage 0is Renal Pelvis and Ureter Urothelial Carcinoma), [NCIT:C27880](http://purl.obolibrary.org/obo/NCIT_C27880) (Intraurothelial Neoplasia), [NCIT:C6149](http://purl.obolibrary.org/obo/NCIT_C6149) (Stage 0 Ureter Urothelial Carcinoma), [NCIT:C6203](http://purl.obolibrary.org/obo/NCIT_C6203) (Stage 0a Ureter Urothelial Carcinoma), [NCIT:C6188](http://purl.obolibrary.org/obo/NCIT_C6188) (Stage 0 Bladder Urothelial Carcinoma), [NCIT:C6202](http://purl.obolibrary.org/obo/NCIT_C6202) (Stage 0a Renal Pelvis Urothelial Carcinoma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192) (Inverted Urothelial Papilloma), [NCIT:C37266](http://purl.obolibrary.org/obo/NCIT_C37266) (Bladder Flat Intraepithelial Lesion), [NCIT:C5061](http://purl.obolibrary.org/obo/NCIT_C5061) (Urethral Urothelial Papilloma), [NCIT:C6193](http://purl.obolibrary.org/obo/NCIT_C6193) (Stage 0 Renal Pelvis Urothelial Carcinoma), [NCIT:C4528](http://purl.obolibrary.org/obo/NCIT_C4528) (Renal Pelvis Urothelial Papilloma), [NCIT:C4529](http://purl.obolibrary.org/obo/NCIT_C4529) (Stage 0is Ureter Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity))) 40.36%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([NCIT:C54557](http://purl.obolibrary.org/obo/NCIT_C54557) (Renal Pelvis Urothelial Cell))) 40.36%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CL:1001428](http://purl.obolibrary.org/obo/CL_1001428) (bladder urothelial cell))) 40.36%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CL:1001319](http://purl.obolibrary.org/obo/CL_1001319) (bladder cell))) 40.36%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CL:1000600](http://purl.obolibrary.org/obo/CL_1000600) (lower urinary tract cell))) 40.36%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) 33.87%
- [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 33.87%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) and [CL:0000244](http://purl.obolibrary.org/obo/CL_0000244) (transitional epithelial cell) 33.87%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CHEBI:22868](http://purl.obolibrary.org/obo/CHEBI_22868) (bile salt))) 33.87%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CHEBI:22563](http://purl.obolibrary.org/obo/CHEBI_22563) (anion))) 33.87%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CHEBI:17089](http://purl.obolibrary.org/obo/CHEBI_17089) (glycoprotein))) 33.87%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CHEBI:16990](http://purl.obolibrary.org/obo/CHEBI_16990) (bilirubin))) 33.87%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CHEBI:16541](http://purl.obolibrary.org/obo/CHEBI_16541) (protein polypeptide chain))) 33.87%
- [CL:0000731](http://purl.obolibrary.org/obo/CL_0000731) (urothelial cell) and (not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid))) 33.87%


